Industries > Pharma > Global Antibacterial Drugs Market 2019-2029

Global Antibacterial Drugs Market 2019-2029

Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems and Others

PUBLISHED: 25 April 2019
PAGES: 297
PRODUCT CODE: PHA0377
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1

The global antibacterial drugs market is estimated to have reach $43bn in 2018 and is expected to grow at a CAGR of 2% in the first half of the forecast period. The Cephalosporins submarket held 28% of the global antibacterial drugs market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 297-page report you will receive 144 tables and 105 figures– all unavailable elsewhere.

The 297-page report provides clear detailed insight into the global antibacterial drugs market analysis. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Antibacterial Drugs Market forecasts from 2019-2029

Revenue forecasts for the 6 leading submarkets from 2019-2029:
• Cephalosporins
• Penicillins
• Fluoroquinolones
• Macrolides
• Carbapenems
• Others

Revenue forecasts for the 43 leading marketed antibacterial drugs from 2019-2029:
Cephalosporins: Rocephin, Sulperazon, Ceftin/Zinnat, Meiact, Flomox, Teflaro, Zeftera, Ceftolozane-tazobactam, Ceftazidime-Avibactam
Penicillins: Generic amoxicillin, Augmentin, Zosyn/Tazocin, Unasyn, Generic amoxicllin-clavulanic acid, Amoxil
Fluoroquinolones: Avelox, Cravit, Vigamox, Ciprodex, Cipro/Ciprobay, Geninax, Defafloxacin
Macrolides: Biaxin/Clarith, Zithromax, Dalacin, Dificid, Solithromycin
Carbapenems: Invanz, Merrem/Meropen, Primaxin, Doribax
Other antibacterial drugs: Zyvox, Cubicin, Tygacil, TOBI/TIP, Solodyn, Vibativ, Sirturo, Tedizolid, Oritavancin, Dalbavancin, Nemonoxacin, Surotomycin

Revenue forecasts for the leading regional markets forecasted in this report are the following:
• North America
• Europe
• Asia-Pacific
• RoW

Each regional market is further segmented by the 6 leading submarkets.

Revenue forecasts for the leading national markets forecasted in this report are the following:
• The US
• Japan
• Italy
• France
• The UK
• Spain
• Germany
• China
• India
• Brazil
• Russia
• South Korea

Global Antibacterial Drugs Market 2019-2029

This report discusses the selected leading companies:
• Adenium Biotech ApS,
• Allecra Therapeutics GmbH
• AstraZeneca
• Bayer
• BioVersys AG
• Eli Lilly
• GlaxoSmithKline (GSK)
• Merck & Co.
• Novartis
• Pfizer

Analysis of the strengths, weaknesses as well as the opportunities and threats of the antibacterial drugs industry and market

Coverage of antibacterial drug candidates in the R&D pipeline. Discussions of research and development – see progress in this industry, finding technological, clinical and commercial outlooks and opportunities

• Key Questions Answered by this Report:
• Gain forecasts from 2019 to 2029 for the overall world market and its leading submarkets, as well as those for prominent national markets.
• Explore the regulatory landscape for leading regional and national markets, as well as expected developments for the period 2019-2029.
• Identify drug development trends that will affect market participants from 2019 to 2029. This report contains SWOT and STEP analysis for the forecast period.
• See discussions of companies developing, manufacturing and marketing antibiotics, exploring products, technologies, R&D, partnerships, M&A and outlooks.

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Antibacterial Drugs Market. You find data, trends and predictions.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Antibacterial Drugs Market 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Antibacterial Drugs Market 2019-2029


Latest Pharma news

Visiongain Publishes Single-Cell Analysis Market Report 2022-2032

The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

26 May 2022

READ

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

READ

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

READ

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

READ

Categories